Print Friendly, PDF & Email

NCT/Study#

NCT04577807 /

LUMINOS-102

PVSRIPO with and without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma

DISEASE GROUP:

Skin and Soft Tissue

current phase:

Phase II

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587